Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Aviptadil for Cough and Quality of Life in Pulmonary Sarcoidosis
2017-004219-37Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Jul 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary sarcoidosis and sarcoidosis comparing Inhaled aviptadil with Placebo (2 arms). Started Jul 2020; status: completed.
02
Drugs
aviptadil
03
Conditions
pulmonary sarcoidosissarcoidosis
Beyond the preview
Go deeper on 2017-004219-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004219-37.